Could a diabetes drug help people with HIV lose weight and fight inflammation?
NCT ID NCT06935838
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 29 times
Summary
This study is testing whether tirzepatide, a drug already used for diabetes and weight loss, can help overweight or obese people with well-controlled HIV lose weight and reduce chronic inflammation. Twelve adults will receive weekly injections for 12 weeks, with doses gradually increased. Researchers will track weight, body composition, liver fat, and markers of inflammation and heart health. The goal is to see if this approach can improve overall health in people living with HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John A Burns School of Medicine
RECRUITINGHonolulu, Hawaii, 96813, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.